EQT Launches All-Cash Takeover Bid for QIAGEN
EQT is trading near its 52-week low of $47.937 (13% above the low).
Summary
EQT Private Equity announced a recommended voluntary all-cash public takeover offer for QIAGEN, an initial-stage bid with no binding price or terms disclosed yet. The deal would consume 10-15% of the €23B EQT XI flagship fund, which is now activated with fees commenced, while the prior EQT X fund sits at 85-90% invested. This is the third major deployment headline in recent weeks, following the $2B McGill insurance-broker acquisition and the A$3.095 per share Cleanaway scheme in Australia, showing EQT is running a heavy deal cadence. An all-cash offer typically sets a floor under QIAGEN shares and pulls the target toward the offer level, but the absence of a stated price, regulatory clearances, and target board approval details keeps the immediate read preliminary.
At the time of this announcement, EQT was trading at $54.17 on NYSE in the Finance sector, with a market capitalization of approximately $33.8B. The 52-week trading range was $47.94 to $68.24. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.